脂质体
聚乙二醇
PEG比率
体内分布
化学
药代动力学
体内
多元醇
色谱法
生物化学
体外
药理学
有机化学
医学
生物
生物技术
财务
聚氨酯
经济
作者
Huali Chen,Qianyu Zhang
出处
期刊:Nanomedicine
[Future Medicine]
日期:2022-06-01
卷期号:17 (14): 1027-1035
被引量:5
标识
DOI:10.2217/nnm-2022-0101
摘要
Background: Polyglycerol (PG) is a type of biocompatible hydrophilic polyether polyol, and it is considered as a potential alternative to polyethylene glycol (PEG) in modifying nanomedicines. Materials & methods: Polyglycerol fatty acid esters (PGFEs) were modified onto liposomes and their serum stability, pharmacokinetics, in vivo distribution and the capacity to induce anti-PEG IgM were compared with PEGylated liposomes (PEG-Lips). Results: Polyglycerol 10-monostearate (PG-10-MS) displayed considerable serum stability and compatibility with mice red blood cells, and it significantly prolonged the blood circulation of liposomes in the pharmacokinetics study compared with the unmodified liposomes, with a similar biodistribution pattern to that of the PEG-Lips. Moreover, PGFE-modified liposomes were less likely to induce the production of anti-PEG IgM. Conclusion: PGFEs could be considered as good candidates to replace PEG lipids for the preparation of liposomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI